Fig. 1From: Human CD133-positive hematopoietic progenitor cells enhance the malignancy of breast cancer cellsIsolation and identification of human CD133 + CD34+ HPCs. Flow cytometry analysis showing the purity of CD133+ HPCs (a); and CD133- HUCBCs (b)Back to article page